Amid consumer angst and political pressure over the cost of life-saving insulin, Sanofi announced Thursday it would slash the price of its most-prescribed insulin, Lantus. Sanofi said it will cut the ...

Hunter Sego, 26, of Indiana, had been spending about $660 each month on insulin from the drugmaker Eli Lilly. When the company announced earlier this month that it would be capping the out-of-pocket ...

Sanofi is cutting the list price of Lantus, its most widely prescribed insulin in the US, by 78% and establishing a $35 monthly cap for those with private insurance, the company announced Thursday.

Early each year, Kristin Thompson-Lerberg sits down with her husband to plan how they’ll reach their family’s insurance policy’s $3,000 deductible. The conversation is always short: Thompson-Lerberg ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Allie Kelly Every time Allie publishes a story, you’ll get an alert straight to your inbox!

Sanofi will cap the out-of-pocket cost of its most popular insulin, Lantus, at $35 per month for people with private insurance, the French drugmaker said Thursday. The change will take effect Jan. 1, ...

Following the lead of its rivals, Sanofi will cut the price of its most widely prescribed insulin in the U.S. by 78% and also place a $35 cap on out-of-pocket costs for commercially insured patients ...

Consumers who are struggling to get discounted insulin due to pharmacy restrictions and red tape will soon have another option to order the life-saving medication needed by millions of people. Amazon ...